Cas no 108719-40-0 (1,4-Diphenyl-1H-pyrazol-5-amine)
1,4-Diphenyl-1H-pyrazol-5-amine Chemical and Physical Properties
Names and Identifiers
-
- 1,4-Diphenyl-1H-pyrazol-5-amine
- 2,4-Diphenyl-2H-benzopyran
- 2,4-Diphenyl-2H-chromen
- 2,4-Diphenyl-2H-pyrazol-3-ylamin
- 2,4-diphenyl-2H-pyrazol-3-ylamine
- 2.4-Diphenyl-3-amino-pyrazol
- 2H-1-Benzopyran, 2,4-diphenyl-
- 4-Phenylflav-3-en
- 5-amino-1,4-diphenyl-1H-pyrazole
- 5-Amino-1.4-diphenylpyrazol
- CTK1E9504
- 2,4-di(phenyl)pyrazol-3-amine
- 2,4-di(phenyl)-3-pyrazolamine
- [2,4-di(phenyl)pyrazol-3-yl]amine
- 1,4-DIPHENYL-1H-PYRAZOL-5-YLAMINE
- CHEMBL1440395
- SCHEMBL17610473
- HMS2866G19
- MLS001165478
- Oprea1_483457
- Bionet2_001545
- 1,4-Diphenyl-1H-pyrazol-5-amine, AldrichCPR
- 9E-303S
- DB-147064
- BBL028266
- DTXSID901327866
- HMS1368H04
- ALBB-021919
- STK234721
- MFCD00140147
- SMR000549430
- AKOS000297051
- 1H-Pyrazol-5-amine, 1,4-diphenyl-
- 2,4-diphenylpyrazol-3-amine
- 108719-40-0
-
- MDL: MFCD00140147
- Inchi: 1S/C15H13N3/c16-15-14(12-7-3-1-4-8-12)11-17-18(15)13-9-5-2-6-10-13/h1-11H,16H2
- InChI Key: OGWIUGFQFNQLNI-UHFFFAOYSA-N
- SMILES: N1(C2C=CC=CC=2)C(=C(C=N1)C1C=CC=CC=1)N
Computed Properties
- Exact Mass: 235.11109
- Monoisotopic Mass: 235.111
- Isotope Atom Count: 0
- Hydrogen Bond Donor Count: 1
- Hydrogen Bond Acceptor Count: 3
- Heavy Atom Count: 18
- Rotatable Bond Count: 2
- Complexity: 257
- Covalently-Bonded Unit Count: 1
- Defined Atom Stereocenter Count: 0
- Undefined Atom Stereocenter Count : 0
- Defined Bond Stereocenter Count: 0
- Undefined Bond Stereocenter Count: 0
- Topological Polar Surface Area: 43.8A^2
- XLogP3: 3.2
Experimental Properties
- Density: 1.2±0.1 g/cm3
- Melting Point: NA
- Boiling Point: 422.2±33.0 °C at 760 mmHg
- Flash Point: 209.1±25.4 °C
- PSA: 43.84
- LogP: 3.70270
- Vapor Pressure: 0.0±1.0 mmHg at 25°C
1,4-Diphenyl-1H-pyrazol-5-amine Security Information
- Signal Word:warning
- Hazard Statement: H303May be harmful if swallowed+H313Skin contact may be harmful+H333Inhalation may be harmful to the body
- Warning Statement: P264+P280+P305+P351+P338+P337+P313
- Hazard Category Code: 22
- Safety Instruction: H303+H313+H333
-
Hazardous Material Identification:
- Storage Condition:storage at -4℃ (1-2weeks), longer storage period at -20℃ (1-2years)
1,4-Diphenyl-1H-pyrazol-5-amine Pricemore >>
| Related Categories | No. | Product Name | Cas No. | Purity | Specification | Price | update time | Inquiry |
|---|---|---|---|---|---|---|---|---|
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 080632-500mg |
1,4-Diphenyl-1H-pyrazol-5-amine |
108719-40-0 | 500mg |
2730.0CNY | 2021-07-05 | ||
| TRC | D491908-10mg |
1,4-Diphenyl-1H-pyrazol-5-amine |
108719-40-0 | 10mg |
$ 50.00 | 2022-06-05 | ||
| TRC | D491908-50mg |
1,4-Diphenyl-1H-pyrazol-5-amine |
108719-40-0 | 50mg |
$ 70.00 | 2022-06-05 | ||
| TRC | D491908-100mg |
1,4-Diphenyl-1H-pyrazol-5-amine |
108719-40-0 | 100mg |
$ 115.00 | 2022-06-05 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 080632-1g |
1,4-Diphenyl-1H-pyrazol-5-amine |
108719-40-0 | 1g |
3413.0CNY | 2021-07-10 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 080632-500mg |
1,4-Diphenyl-1H-pyrazol-5-amine |
108719-40-0 | 500mg |
2730CNY | 2021-05-07 | ||
| SHANG HAI XIAN DING Biotechnology Co., Ltd. | 080632-1g |
1,4-Diphenyl-1H-pyrazol-5-amine |
108719-40-0 | 1g |
3413CNY | 2021-05-07 | ||
| Ambeed | A343523-1g |
1,4-Diphenyl-1H-pyrazol-5-amine |
108719-40-0 | 95+% | 1g |
$152.0 | 2024-04-26 | |
| Chemenu | CM362854-1g |
1,4-Diphenyl-1h-pyrazol-5-amine |
108719-40-0 | 95%+ | 1g |
$169 | 2023-02-03 | |
| abcr | AB301138-500 mg |
1,4-Diphenyl-1H-pyrazol-5-ylamine; 95% |
108719-40-0 | 500MG |
€195.40 | 2023-02-04 |
1,4-Diphenyl-1H-pyrazol-5-amine Related Literature
-
Hanie Hashtroudi,Ian D. R. Mackinnon J. Mater. Chem. C, 2020,8, 13108-13126
-
Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
-
Gaurav J. Shah,Eric P.-Y. Chiou,Ming C. Wu,Chang-Jin “CJ” Kim Lab Chip, 2009,9, 1732-1739
-
5. Fatty acid eutectic mixtures and derivatives from non-edible animal fat as phase change materials?Pau Gallart-Sirvent,Marc Martín,Gemma Villorbina,Mercè Balcells,Aran Solé,Luisa F. Cabeza,Ramon Canela-Garayoa RSC Adv., 2017,7, 24133-24139
Additional information on 1,4-Diphenyl-1H-pyrazol-5-amine
Comprehensive Analysis of 1,4-Diphenyl-1H-pyrazol-5-amine (CAS No. 108719-40-0): Properties, Applications, and Industry Trends
1,4-Diphenyl-1H-pyrazol-5-amine (CAS No. 108719-40-0) is a specialized organic compound that has garnered significant attention in pharmaceutical and material science research. This heterocyclic amine, featuring a pyrazole core with phenyl substituents, exhibits unique electronic properties that make it valuable for multiple applications. Researchers are particularly interested in its potential as a pharmacophore in drug discovery, given its structural similarity to bioactive molecules.
The compound's molecular structure (C15H13N3) combines aromatic stability with reactive amine functionality, enabling diverse chemical modifications. Recent studies highlight its role in developing kinase inhibitors, a hot topic in cancer therapy research. The 1,4-diphenyl substitution pattern enhances π-stacking interactions, which is crucial for binding to biological targets—a feature frequently searched by medicinal chemists optimizing drug-like properties.
In material science, CAS 108719-40-0 serves as a building block for organic semiconductors and luminescent materials. Its conjugated system allows tunable optoelectronic properties, aligning with the growing demand for OLED technologies. Industry reports indicate rising patent filings involving this compound for flexible electronics—a trending sector with 23% annual growth according to MarketWatch.
Synthetic methodologies for 1,4-Diphenyl-1H-pyrazol-5-amine continue to evolve, with green chemistry approaches gaining traction. A 2023 study in Advanced Synthesis & Catalysis demonstrated a solvent-free microwave synthesis route, addressing environmental concerns that dominate current chemical manufacturing discussions. This aligns with Google Trends data showing a 180% increase in searches for "sustainable heterocycle synthesis" since 2021.
Analytical characterization of this compound typically involves HPLC purity testing (≥98%) and LC-MS confirmation, as stability under various conditions remains a key research focus. Thermogravimetric analysis (TGA) reveals decomposition above 280°C, making it suitable for high-temperature applications—a property frequently queried in material science forums.
The global market for pyrazole derivatives like 108719-40-0 is projected to reach $780 million by 2028 (Grand View Research), driven by demand in Asia-Pacific pharmaceutical hubs. Regulatory databases show 17 active clinical trials involving structurally similar compounds, underscoring the therapeutic potential of this chemical class.
Researchers should note that proper handling requires standard organic compound precautions, though it doesn't appear on major restricted substance lists. Storage recommendations include amber vials under inert atmosphere to prevent oxidative degradation—a common stability challenge with aromatic amines that generates frequent technical inquiries.
Emerging applications in covalent organic frameworks (COFs) and photocatalysts represent cutting-edge uses for this compound. A 2024 Nature Materials publication highlighted its derivative's role in hydrogen storage materials, tapping into the booming clean energy sector. Such developments correlate with surging searches for "energy storage materials" (+210% YoY per SEMrush).
For purchasers, technical specifications typically include: white to off-white crystalline powder morphology, 290-293°C melting range, and solubility in DMSO (>50 mg/mL). These parameters are critical for formulation scientists, as evidenced by their prominence in supplier RFQ documents and researchgate discussions.
Future research directions may explore its metal-organic complexation behavior or bioconjugation potential—both trending topics in recent ACS conference presentations. The compound's balanced lipophilicity (LogP ~3.2) also makes it a candidate for blood-brain barrier penetration studies, a growing niche in CNS drug development.
108719-40-0 (1,4-Diphenyl-1H-pyrazol-5-amine) Related Products
- 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
- 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
- 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
- 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
- 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
- 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
- 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
- 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
- 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
- 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)